Article
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.
JCO precision oncology - 1 Jan 2022
Treis Diana, Umapathy Ganesh, Fransson Susanne, Guan Jikui, Mendoza-García Patricia, Siaw Joachim T, Wessman Sandra, Gordon Murkes Lena, Stenman Jakob J E, Djos Anna, Elfman Lotta H M, Johnsen John Inge, Hallberg Bengt, Palmer Ruth H, Martinsson Tommy, Kogner Per
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.